GLP-1 meds prompt rethink of obesity and eating disorder care

Obesity and eating disorders person traditionally been treated arsenic abstracted areas of wellness care—but the accelerated emergence of GLP-1 medicines is progressively bringing the 2 together. Adelaide University researchers accidental the increasing usage of medicines specified arsenic Ozempic and Mounjaro is highlighting an underrecognized overlap betwixt the conditions—and raising important questions astir who could payment and who whitethorn beryllium astatine risk.